{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03936335",
            "orgStudyIdInfo": {
                "id": "R668-AD-1760"
            },
            "organization": {
                "fullName": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)",
            "officialTitle": "Dupilumab and Pregnancy Outcomes: A Retrospective Cohort Study Using Administrative Healthcare Databases (Dupi PODS)",
            "therapeuticArea": [
                "Women's Health",
                "Dermatology"
            ],
            "study": "an-observational-retrospective-cohort-study-being-conducted-in-women-with-atopic-dermatitis-ad"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-09-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-07-21",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-07-21",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-04-30",
            "studyFirstSubmitQcDate": "2019-04-30",
            "studyFirstPostDateStruct": {
                "date": "2019-05-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-05-11",
            "lastUpdatePostDateStruct": {
                "date": "2023-05-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Sanofi",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this study is to describe and compare the incidence of adverse pregnancy outcomes (spontaneous abortion/miscarriage, stillbirth) and prevalence of infant outcomes (major congenital malformations \\[MCMs\\], small for gestational age \\[SGA\\]) in women with AD who are treated with dupilumab during pregnancy relative to women with AD who are not treated with dupilumab during pregnancy."
        },
        "conditionsModule": {
            "conditions": [
                "Adverse Pregnancy Outcomes",
                "Atopic Dermatitis"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "RETROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 3930,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dupilumab cohort",
                    "description": "Exposed to dupilumab during the relevant exposure window:\n\n* First trimester\n* Pregnancy",
                    "interventionNames": [
                        "Drug: dupilumab"
                    ]
                },
                {
                    "label": "Other systemic therapy or phototherapy cohort",
                    "description": "Exposed to systemic medications other than dupilumab or to phototherapy during the relevant exposure window:\n\n* First trimester\n* Pregnancy"
                },
                {
                    "label": "Unexposed cohort",
                    "description": "* Not exposed to systemic medications (including dupilumab) or phototherapy; and\n* Received topical prescription therapy, or a second diagnosis for AD on a date that differs from the base population qualifying AD diagnosis date during the relevant exposure window:\n* First trimester\n* Pregnancy"
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "dupilumab",
                    "description": "No study drug will be administered. This study is based on an analysis of automated medical and prescription claims, supplemented by information abstracted from the medical record.",
                    "armGroupLabels": [
                        "Dupilumab cohort"
                    ],
                    "otherNames": [
                        "REGN668",
                        "Dupixent\u00ae",
                        "SAR23189"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of major congenital malformations",
                    "description": "Initially identified through the presence of corresponding codes on the insurance claims, confirmed through medical record review for infant outcomes: 01 April 2017 through 31 July 2023",
                    "timeFrame": "Up to 21 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of spontaneous abortion or miscarriage",
                    "description": "Identified through the presence of corresponding codes on the insurance claims for pregnancy outcomes: 01April 2017 through 31 March 2024",
                    "timeFrame": "Up to 9 months"
                },
                {
                    "measure": "Incidence of stillbirth",
                    "description": "Identified through the presence of corresponding codes on the insurance claims for pregnancy outcomes: 01April 2017 through 31 March 2024",
                    "timeFrame": "Up to 9 months"
                },
                {
                    "measure": "Incidence of small for gestational age",
                    "description": "Identified through the presence of corresponding codes on the insurance claims for infant outcomes: 01 April 2017 through 31 July 2023",
                    "timeFrame": "Up to 21 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Continuous medical and pharmacy benefit coverage for at minimum 6 months prior to and including the estimated LMP\n* Diagnosis code indicative of AD in the period from up to 1 year prior to the estimated LMP through the end of the pregnancy\n\nNote: Other Protocol Defined Inclusion / Exclusion Criteria Apply",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "minimumAge": "18 Years",
            "maximumAge": "49 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "Adult women with AD who are pregnant between 01 April 2017 and 31 March 2024 (with the start of pregnancy to be defined by the estimated last menstrual period (LMP))",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials Administrator",
                    "role": "CONTACT",
                    "phone": "844-734-6643",
                    "email": "clinicaltrials@regeneron.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trial Management",
                    "affiliation": "Regeneron Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Regeneron Research Site",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003876",
                    "term": "Dermatitis, Atopic"
                },
                {
                    "id": "D000003872",
                    "term": "Dermatitis"
                },
                {
                    "id": "D000004485",
                    "term": "Eczema"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000017443",
                    "term": "Skin Diseases, Eczematous"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7071",
                    "name": "Dermatitis, Atopic",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7067",
                    "name": "Dermatitis",
                    "asFound": "Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7655",
                    "name": "Eczema",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M19712",
                    "name": "Skin Diseases, Eczematous",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}